KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 128 filers reported holding KURA ONCOLOGY INC in Q4 2019. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $725,204 | -13.8% | 79,518 | 0.0% | 0.02% | -10.0% |
Q2 2023 | $841,300 | -13.5% | 79,518 | 0.0% | 0.02% | -31.0% |
Q1 2023 | $972,505 | +176.0% | 79,518 | +180.0% | 0.03% | +190.0% |
Q4 2022 | $352,382 | -81.0% | 28,395 | -50.0% | 0.01% | -76.2% |
Q4 2020 | $1,856,000 | -39.5% | 56,838 | -43.3% | 0.04% | -52.3% |
Q3 2020 | $3,070,000 | +87.2% | 100,193 | -0.4% | 0.09% | +87.2% |
Q2 2020 | $1,640,000 | +56.8% | 100,606 | -4.3% | 0.05% | +23.7% |
Q1 2020 | $1,046,000 | -30.5% | 105,082 | -4.0% | 0.04% | +2.7% |
Q4 2019 | $1,505,000 | -13.3% | 109,465 | -4.3% | 0.04% | -14.0% |
Q3 2019 | $1,735,000 | -27.5% | 114,344 | -5.9% | 0.04% | -24.6% |
Q2 2019 | $2,392,000 | -73.5% | 121,487 | -77.7% | 0.06% | -46.7% |
Q1 2019 | $9,026,000 | +109.8% | 544,118 | +77.6% | 0.11% | 0.0% |
Q4 2018 | $4,302,000 | -36.3% | 306,420 | -20.6% | 0.11% | -15.1% |
Q3 2018 | $6,753,000 | +281.3% | 385,873 | +296.6% | 0.13% | +281.8% |
Q2 2018 | $1,771,000 | – | 97,294 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |